There is no way to stop scientific progress. Modern biology is a double-edged sword. The key question is: whose are the hands holding the biological agent, for example, an instrument for manipulating the anthrax bacteria or the bird flu virus H5N1 genes? Typically, this instrument would be locked up in a safeguarded laboratory located in a developed democratic country. It is not good any longer if it happens to be in the hands of avaricious researchers from a weak and collapsing economy that are ready to sell it to a "trustworthy and moneyed business partner from the East".
A large amount of antibiotics in the armoury of a greedy owner of a fish breeding farm, a gigantic poultry or pig farm is a hazard when these people, ignoring international laws, start seeking for illegal additional profit of a million dollars. This could possibly happen in a country where labour is cheap and law is weak.
Bioterrorism threat is rapidly increasing worldwide. This is fuelled both by political processes and scientific progress. The microorganisms causing dangerous infectious diseases that can be used as biological weapons have been thoroughly researched, and the information often is broadly accessible, including for potential terrorists. To arrange a bioterrorism act is much less costly, less conspicuous and therefore more realistic than any other type of broad-based attack to a country or a group of countries.
Currently there is no uniform definition of terrorism that would be correct from the legal aspect. As a matter of fact, terrorism is a violent combat method that one group of people exercises against another group of people having an alternative persuasion, with a purpose to attain political, religious or other goals. Biological terrorism or bioterrorism is a deliberate dissemination of a biological agent, for example, a pathogenic microorganism, with the purpose to cause a human disease and death, and to create confusion, panic and fear in the society.
According to the experts, the use of biotechnology methods for terroristic aims is an ever increasing reality; consequently, the risks of bioterrorism are rapidly building up as well. The use of one or several biological agents with terroristic aims is unavoidable. Under certain circumstances, most of infectious diseases can be dangerous both to an individual and to the society. However, some microbes are especially hazardous, because they are highly contagious, pathogenic and virulent. Human infections and parasitic diseases are particularly dangerous. They have a capability of developing a malignant clinical course, spreading rapidly, and in such situation an absence of effective preventive measures and treatment will jeopardise the health of each individual and the society in general.
According to the USA Department of Homeland Security, the most dangerous microorganisms are Variola major, Bacillus anthracis, multidrug resistant Bacillus anthracis, Yersinia pestis, Rickettsia prowazekii, the Ebola virus, the Marburg virus, Clostridium botulinum toxine, Burkholderia mallei, Burkholderia pseudomallei, Francisella tularensis.
To a large extent, people themselves have made these causal agents resistant and have created mutations. The idea of any living being is survival, and this is true in respect of an individual in short-term as well as in respect of a group of similar individuals, such as species. Life on the Earth is a struggle to survive, and it is on-going at multiple levels. As soon as man discovered antibiotics, bacteria started their struggle to survive -they had an option to develop resistance or to die. The strongest survived. From the physicians' point of view, these robust and resistant bacteria are the bad ones, while from the point of view of other bacteria they are the heroes. Now it is time that man and the human race start their struggle to survive in the occasion of a bioterrorism act or a highly resistant pathogenic microbe or a modified virus stem spreads. Let me remind you that in 2014 Yoshihiro Kawaoka from the University of Wisconsin-Madison in the USA modified the H1N1 bird flu virus stem that it is no longer recognised by a human immune system. Such virus becomes exceedingly dangerous and is a potential causal agent of a new pandemic! The World Medical Association is the sole global organisation that has the ability of creating a synthesis of medical, preventive, economic and political aspects for preserving the continuity of mankind. We are facing serious challenges. Let us start with the "One World, one Health" approach, and this year let us start waging war against unjustified use of antibiotics on a global scale.
Council
The 203 rd Council meeting at the Sheraton Convention Centre in Buenos Aires, Argentina was officially opened by Dr. Ardis Hoven, Chair of Council. Her first task was to welcome Dr. Jorge Lemus, Argentina's Minister of Health, to officially open the proceedings. Dr . Lemus spoke about the new health challenges facing the medical profession and the importance of the social determinants of health and issues such as poverty, lack of health, housing and proper drinking water. This meant that health and wellbeing was an inter-sectorial matter where they had to establish partnerships with other sectors in order to meet their goals. He had been emphasising the importance of the social determinants for many years. This was a key issue in tackling the problems of Argentina and the region, as well as globally. At present the region was also faced with the Zika virus, which was an environmental matter due to the tropicalisation of the weather. These were issues facing physicians and he hoped that the WMA meeting would reach important decisions. Dr. Jorge Coronel, President of the Medical Confederation of the Republic of Argentina, welcomed more than 100 WMA delegates from 35 national medical associations. He spoke about the need for the active participation of physicians in solving the problems facing Argentina, including violence which was seen in hospitals and clinics. There had been deaths of physicians, which was a matter for enormous sadness. It was also the fact that physicians' working conditions needed to be improved. Doctors lacked the necessary means and materials to take care of patients.
The WMA Secretary General Dr. Otmar Kloiber reported that there were two new members of Council, Prof Brian. Owler representing the Australian Medical Association, who was present, and Dr. Mark Porter from the British Medical Association, who was not able to be present, because of industrial action by the junior doctors in England.
President's Report
In his interim report, WMA President Sir Michael Marmot reminded the meeting that his mission as President was to encourage doctors' involvement in the social determinants of health and health equity. To support this mission, he had set out three aims -that the WMA issue a statement on social determinants of health and health equity and produce a supporting publication that would answer the question: "what do we do?"; to promote regional networking; and to support post-graduate education and training. He said the WMA statement had been issued as the Declaration of Oslo and a document had been introduced answering the question from physicians about what they could do. This emphasised five domains of activity -education and training, seeing the patient in a broader perspective, the health service as employer and its impact on the local community, working in partnership and advocacy. On networking, he reported keen interest from most regions of the world and gave examples from the Americas, Africa, Europe, Asia and Oceania. Sir Michael concluded by saying that he had been enormously impressed by the enthusiasm he had encountered among physicians on the social determinants of health and he ended with the words: ' We are all working in the cause of social justice and health'. Dr. Kloiber submitted a lengthy written report about the activities of the Association over the past year. He spoke briefly about new translations of the WMA's Medical Ethics manual. He also reminded Council about two forthcoming meetings, the World Health Professions Alliance Conference on Regulation in Geneva (May 21 and 22) and the One Health Conference, in Fukuoka, Japan (Nov. 10-11) together with the Japan Medical Association and the Japan Veterinary Association.
Secretary General's Report
Chair's Report Dr. Hoven submitted her written report. She referred to the Governance Work Group and said that it was larger than normal work groups because it was important to have as much diversity as possible in the representation. In addition to those that had expressed an interest in participating, representation from the Junior Doctors Network, the Associate members, and Past Presidents and Chairs group had been included in the work group. She looked forward to their efforts on behalf of the WMA and was optimistic that a more transparent and representative organization would be accomplished in order to maximize the Association's advocacy and impact throughout the world. Referring to the WMA Expert Meeting on Health Databases in Seoul that had been held, Dr. Hoven said she had been impressed by the depth of knowledge of those involved and the detailed examination of information necessary to successfully complete this work. She said it was imperative that they listened to all the voices speaking. She also looked forward to attending for the first time the WMA Caring Physicians of the World Medical Leadership, Communication and Advocacy Course in Jack-203 rd WMA Council Session, Buenos Aires, April 2016 BACK TO CONTENTS sonville, Florida and said that this course through the years had received great ratings from those who have attended from national medical associations (NMAs).
Emergency Resolution
The Turkish Medical Association submitted an emergency Resolution on Refugees and Migrants, presented by Dr. Bayazit Ilhan. He said the Resolution was based on a communique following the symposium held in February in Istanbul on War, Migration and Health. Large numbers of people were presenting at borders seeking refuge or asylum. Some were fleeing war zones or other conflicts, others were fleeing from desperate poverty, violence and other appalling injustices and abuse. The global community was ill prepared for this mass movement of people and had responded by closing borders, seeking to turn back the influx. What should physicians do in these circumstances? He said the emergency Resolution included a number of recommendations emerging from the symposium.
Delegates agreed that the Resolution should be considered by Council later in the meeting.
Medical Ethics Committee
Dr. Heikki Pälve (Finnish Medical Association) took the Chair. The Committee received the Secretary General's oral report. Dr. Kloiber said several important issues had emerged since the Moscow Assembly. The first was the occurrence of gene editing systems, which had raised some ethical concerns around the world. For the first time it gave the opportunity to do germ line changes in our genetic inheritance and this was something that had ethical implications and which the WMA had to look into. The second item referred to research ethics according to the Declaration of Helsinki and the work of ethics committees. These were issues the WMA needed to consider.
The third item was the work being carried out on medical ethics in times of armed conflict, which had been referred to the Security Council of the United Nations.
Person Centered Medicine
The Committee received an oral report of the Person Centered Medicine Work Group, presented by Prof. Vivienne Nathanson (British Medical Association). She said work was proceeding on the basis of definitions drawn up by the group. She hoped that by the next meeting they would be able to present the committee with a draft policy paper.
Health Databases and Biobanks
Dr. Jon Snaedal (Iceland), Chair of the Work Group on Health Databases and Biobanks, gave an oral report about the work of the group considering a proposed Declaration on Ethical Considerations regarding Health Databases and Biobanks. Over the past four years there had been several open expert meetings and the document had gone through almost a dozen revisions. He proposed that the group's current briefing paper be circulated to NMAs and that the Work Group be allowed to include discussion with partners outside the WMA. He hoped that WMA policy would be adopted by the next Assembly in October following another face to face meeting of the Work Group. The committee agreed to circulate the proposed Declaration on Ethical Considerations regarding Health Database and Biobanks to NMAs, that comments be invited from expert organisations outside the WMA and that a further meeting of the Work Group should take place in September to finalise a document to be presented to the Council in Taipei.
Declaration of Geneva
An oral report was given by Dr. Ramin Parsa-Parsi (German Medical Association), Chair of the Work Group considering the revision of the Declaration of Geneva. He said the group was planning a final draft for consideration at the October 2017 General Assembly session in Chicago, because he did not want this work to be confused with the current debate on the high level database policy document. Further discussion would take place at the committee meeting in Taipei in October this year when a draft document would be submitted. Fruitful discussions had been continuing and he urged NMAs to complete and return the survey that had been sent out on the use of the Declaration of Geneva.
Participation of Physicians in Pre-Natal Gender Selection
The Committee considered a Proposed Revision of the WMA Statement on the Participation of Physicians in Pre-Natal Gender Selection submitted by the Swiss Medical Association, which had been circulated to all NMAs. This urges all NMAs to recommend their national governments to adopt laws and regulations that would prohibit the use of prenatal sex-selection for reasons of gender-preference. The Statement calls for the installation of protection mechanisms for those physicians who refuse to participate in pre-natal diagnostic tests and abortions performed solely for reasons of gender preference, excluding sex selection of a fetus or pre-embryo for purposes of avoiding a severe sex-linked disease. After a brief debate it was agreed to send the document back to the rapporteur to analyze in relation to existing WMA policy on related topics. If the substance of the Statement is not sufficiently covered in the existing policies, the Statement will be reconsidered by the committee.
Euthanasia and Physician Assisted Dying
The Royal Dutch Medical Association, together with the Canadian Medical Association, presented a proposed Statement on Euthanasia and Physician Assisted Dying. Speakers from the two NMAs said they were aware these issues were very controversial. What was required was a fair, open and respectful debate on the diversity of views that existed on this issue as well as scope and respect for diverging views. Following a lengthy debate about whether or not to circulate the document among NMAs, it was decided that it should be circulated.
Quality Assurance in Medical Education
Dr. Steven Stack (American Medical Association) proposed a new Declaration on Quality Assurance in Medical Education, addressing the issue of the quality of undergraduate medical education and medical schools. Delegates welcomed the document and the committee agreed it should be circulated to NMAs for consideration.
Classification of 2006 Ppolicies
The committee reviewed the recommendations received for revising medical ethics policies for which it had been 10 years since adoption or last revision.
It recommended the following actions: Council Resolution on Organ Donation in China
The committee agreed to reaffirm the Resolution. Dr. Kloiber said he would contact the Chinese Medical Association to request information on the current situation concerning organ transplantation and whether obtaining organs from prisoners was still practiced in China.
Declaration of Geneva
The committee agreed that consideration of the Declaration be postponed pending the outcome of the Work Group on this document.
International Code of Medical Ethics
The committee agreed that the Code be postponed pending the outcome of the Work Group on this document.
Declaration of Sydney
The committee agreed that the Declaration on the Determination of Death and the Recovery of Organs be reaffirmed with minor revisions.
Declaration on Therapeutic Abortion
It was decided to reaffirm the Declaration with minor revisions.
Declaration of Tokyo with guidelines for Medical Doctors concerning Torture and other Cruel, Inhuman or Degrading Treatment or Punishment in relation to Determination and Imprisonment
Declaration of Venice on Terminal Illness
The committee agreed that this Declaration undergo a major revision.
Declaration of Malta on Hunger Strikers
It was agreed that the Declaration should undergo a major revision.
Statement on Combating HIV/AIDS and the Medical Profession Statement on HIV/AIDS and the Medical Profession
It was agreed that this Statement be rescinded and archived.
Statement on Child Abuse and Neglect
The committee agreed that this Statement be reaffirmed with minor revisions.
Statement on Animal Use in Biomedical Research
It was agreed that this Statement be reaffirmed.
Statement on Patient Advocacy and Confidentiality
The committee agreed that this Statement be reaffirmed.
Statement on Medical Ethics in the Event of Disaster
It was agreed that this Statement be reaffirmed with minor revisions.
Statement on Weapons of Warfare and Their Relation to Life and Health
Statement on Assisted Reproductive Technologies
It was agreed that this Statement undergo a major revision.
Statement on HIV/AIDS and the Medical Profession
Human Rights
Clarisse Delorme, the WMA's Advocacy Advisor, referred to the recent joint Turkish Medical Association/WMA Conference on War, Migration and Health held in Istanbul, and on related activities in Turkey and Egypt.
Socio-Medical Affairs Committee
Dr. Miguel Roberto Jorge (Brazil) took the Chair. Dr. Kloiber spoke about the global activity on the social determinants of health and he urged NMAs to involve themselves in this area. He also said they were still seeing a strong reluctance to immunization around the world. This included poor countries that did not have enough resources to do immunization, as well as a rejection in affluent countries sometimes based on weird arguments. Sometimes, even physicians were involved in spreading this reluctance. He said that a number of NMAs had been working on the issue of illegal drugs and drug overdoses. There had been an increas-BACK TO CONTENTS ing number of fatalities from illegal drugrelated use and from prescription drugs. There was also a global tendency to legalise drugs, for instance in some states in US. Finally, he said that tobacco control had not been properly addressed in many countries and there was still an agenda there for NMAs to consider.
Health Care in Danger
Dr. Bruce Eshaya-Chauvin, from the International Committee of the Red Cross and coordinator of the Health Care in Danger Project, reported on the recent activities of the project. This included a resolution on the ethical principles for health professionals in conflict zones, which was to be discussed in the UN Security Council. Delegates heard a report on the activities of the WMA Workgroup on Health Care in Danger which had met the previous day, including discussion about further incidents of violence against health care professionals.
Role of Physicians in Preventing the Trafficking with Minors and Illegal Adoptions
The Spanish Medical Association reported that the Work Group had met the previous day. It had agreed on a proposal for a WMA Statement on the Role of Physicians in preventing Trafficking with Minors and Illegal Adoptions. This denounces all forms of human trafficking, especially those that involve children, and puts forward proposals for action that physicians could take. It was agreed that the document should be circulated among members for comments. Dr 
Armed conflicts

Ageing
Dr. Nivio Moreira (Brazilian Medical Association) reported on the activities of the Work Group on Ageing. It put forward a proposal for a Statement on Ageing with recommendations to improve the care of elderly people throughout the world. During a debate, delegates discussed the need to include the provision of secondary health care for the elderly, including the psychosocial aspects of managing care. The committee agreed that the document, as amended, be approved by the Council and be forwarded to the General Assembly for adoption.
Boxing
A proposed revision to the WMA Statement on Boxing was introduced by the South African Medical Association. This puts forward new recommendations for additional action to be taken until boxing is completely abolished. In a brief debate, it was decided that the document was not yet ready for adoption and it was agreed to circulate the document to NMAs.
Tobacco
The Committee considered a proposed revision from the Australian Medical Association of the WMA Resolution on the Implementation of the WHO Framework Convention on Tobacco Control. The document, which recognizes the importance of the Framework as a mechanism to protect people from exposure and addiction to tobacco, was approved and the committee agreed to send it to the Council for forwarding to the General Assembly for adoption.
Obesity in Children
A proposed WMA Statement on Obesity in Children was submitted by the Israel Medical Association. There was a debate about whether this document should be combined with the WMA's more general statement on obesity. It was also suggested that the document should highlight more prominently the social determinants of health and the role of educating parents in preventing child obesity. The committee agreed to recirculate the Statement to NMAs for reconsideration and that the Statement on the Physician's Role in Obesity, currently under the 10 years' review process, be examined at the same time, to ensure coherence between the two policies.
Physicians' Right to Information
The committee considered the proposed WMA Declaration on Physicians' Right to Information about the World Medical Association and its Policies, submitted to the Assembly in Moscow by the Russian Medical Society. After considerable debate, the committee recommended that further consideration of the document be postponed to the next meeting in Taipei in October.
Professional Autonomy of Physicians
The committee considered the proposed WMA Declaration on Professional Autonomy of Physicians as the Main Condition for Implementation of the Human Right to Health. The Russian Medical Society, which originally submitted the document, asked for the document to be withdrawn, and this was agreed by the committee.
Fossil Fuel Divestment
The proposed Statement on Divestment in Fossil Fuels was considered. The Statement urges national medical associations to raise awareness of the negative health effects caused by fossil fuel pollution and climate change, and to shift their investment portfolios toward renewable clean energy generation.
After several delegates said that there were still some issues to be resolved, the committee decided the Statement needed further reconsideration and recommended that it should be recirculated to NMAs for comments.
Global Medical Electives
A proposed WMA Statement on Ethical Considerations in Global Medical Electives was considered by the committee. The document from the Junior Doctors Network proposes ethical guidelines concerning medical trainees participating in global educational experiences. After a brief debate the committee recommended the Statement be approved by the Council and forwarded to the General Assembly for adoption.
Health and Environment
Dr. Dongshun Shin, Chair of the Environmental Caucus, reported on the activities of the Caucus that had met earlier that day. The meeting had focused on the outcome and follow-up of the Inter-Governmental Climate Change Conference in Paris in December 2015 and on air pollution. He said it was important to activate national and regional action to raise concern on these issues.
Friday April 29
The second day of the meeting continued with the Socio-Medical Affairs Committee
Female Genital Mutilation
The committee considered a proposed revision of the WMA Statement on Female Genital Mutilation Physicians. This encourages national medical associations to become more active in campaigning to end the practice of female genital mutilation. Prof. Nathanson explained the changes of wording to clarify the document's advice to physicians. After a debate, the committee recommended that the document as amended be approved by the Council and forwarded to the General Assembly for adoption.
Body Searches of Prisoners
The committee considered a proposed revision of the WMA Statement on Body Searches of Prisoners. This led to a debate on clarifying the guidance for physicians who are directed to conduct body searches and the issue of consent. There was also a discussion on the document's reference to searches involving transgender people. Following the debates, the committee recommended that the document, as amended, be approved by the Council and forwarded to the General Assembly for adoption.
Cyber Attacks on Health and other critical infrastructures
The German Medical Association submitted a proposed Statement on Cyber-Attacks on health and other critical infrastructures arguing that the WMA and NMAs should be urging governments to take all necessary measures to guard against this threat. Delegates were told that attacks on critical infrastructure, including hospitals, were on the rise, posing a threat to patients' fundamental right to data privacy and safety. As a result, it was essential to raise awareness of this problem by anticipating and defending against such cyber intrusions. It was argued that physicians were simply not aware of the extent of this problem, which included the risk of records being manipulated. The committee agreed to circulate the paper to NMAs for consideration.
Zika virus
The Committee considered a proposed WMA Statement on the Zika virus infection calling on the World Health Organisation to work with disease control organisations to better understand the natural history and current epidemiology of the infection. It was argued that this was an international health emergency and was going to affect people throughout the world. It was causing a great deal of distress and what physicians needed was consistent advice to use with their patients or for people thinking of travelling to affected areas. Delegates debated whether there should be one statement on pandemics as well as resolutions on specific viruses. The committee agreed that the Statement should be changed into a Resolution. During the debate that followed, various amendments were agreed, and delegates heard reports from Latin American NMAs about the current situation in their countries, including the lack of information being received by physicians. At the conclusion of the debate, the committee agreed that the document, as amended, should be forwarded to the Council for approval.
Medical Tourism
The Israeli Medical Association submitted a proposed Statement on Medical Tourism setting out protocols to protect the right of foreign patients who receive medical treatment abroad. The aim of the guidelines for physicians is to protect patients receiving treatment abroad from any attempt at harm, fraud or unprofessionalism and to preserve the principles of medical ethics for medical tourists and local patients alike. Delegates were told that there was an emerging industry with health systems around the world competing for foreign patients. There was a need for some ethical obligations to protect foreign patients from being taken advantage of. The committee agreed to circulate the document to NMAs.
Medical Cannabis
The South African Medical Association submitted a proposed new Statement on Medical Cannabis. This declares that in the absence of convincing scientific evidence on the therapeutic effectiveness of cannabis, there should be more rigorous research carried out before governments decide to legalise medical cannabis. The committee agreed that the document should be circulated to NMAs for comment.
Classification of 2006 Policies
The committee considered the recommendations received on the potential revision of the SMAC policies for which it has been 10 years since adoption or last revision The committee also agreed that a rapporteur be appointed to undertake a review of the WMA's general policies on alcohol.
Advocacy
Dr. André Bernard (Canadian Medical Association), Chair of the Advocacy Advisory Group, reported on the activities of the group, including a suggestion from the Turkish Medical Association for holding a World Day to recognize the issue of violence against health professionals. He said that the group had considered how to take this idea forward and recommended that further work be carried out on the proposal.
He also said the group was discussing the more general issue of progressing advocacy within the Association.
Finance and Planning Committee
Dr. Dongshun Shin (Korean Medical Association) took the chair.
Membership Dues Payments
The Committee received a report from Mr. Addy Hällmayr, the WMA's Financial Advisor, on Membership Dues Payments for 2015.
Financial Statement
Mr Hällmayr provided a detailed explanation of the pre-audited Financial Statement for 2015 and the committee received the document as an interim financial statement as it will be audited in June 2016. It agreed that the interim Financial Statement for 2015 be approved.
WMA Strategic Plan
An oral report was given by the Secretary General. He said that plans for a new WMA strategic plan would be developed from the input from three workgroups, the Advocacy Advisory Group, Business Development Group and Work Group on Governance Review.
Business Development
The Committee considered a report from the Business Development Group, including possible ways of expanding additional resources through sponsorship within the Association's ethical guidelines and by establishing a foundation trust as a starting point of discussion. It was agreed that the group should continue to study this plan and report back to the council in Taipei.
WMA Statutory Meetings
Plans were discussed for changing the agenda for the 2018 General Assembly 
Junior Doctors Network
The Committee received the report of the Junior Doctors Network. In his written report, the JDN Chair, Dr. Ahmet Murt, highlighted the JDN's activities since October 2015 and its future plans. He said the priority of the JDN in the past year had been to expand the membership, both in quantity and its reach. Its projects, initiatives and the meetings attended all served this purpose. The JDN mailing list now included more junior doctors with a balanced representation across all continents. Communications with regional junior doctors' organisations had been active. The JDN sought to be one of the central organisations in the field of postgraduate medical education. The JDN had played an instrumental role representing the WMA at several meetings. There had been a consensus among the JDN Management Team since last year that a Strategic Plan should be developed in order to better prepare the JDN for the future. A task force had been formed for this purpose and its work was ongoing. Dr. Murt concluded by saying that the JDN was very concerned about the imposition of contracts on junior doctors in England which would have a negative effect on physicians' welfare and also on patient safety. He said he would like to express the JDN's support for the British Medical Association's actions in not accepting this imposition.
Past Presidents and Chair of Council Network
The Committee received a report of the Past Presidents and Chairs of Council Network.
Governance Review
The Committee received a report of the Governance Review Work Group. Prof. van der Gaag, Chair of the Work Group, said five topics had been defined for workgroups to focus on -involvement, inclusiveness and representation; transparency and openness; consistency, efficiency and quality of WMA work; the status of Associate Members; and affordability. He also referred to plans for a survey to be carried out.
Revision of Rules Applicable to WMA Associate Membership
The Committee considered a proposal to consider Revision of Rules Applicable to WMA Associate Membership and agreed that this matter be referred to the Work Group on Governance Review.
World Medical Journal
The Committee received the report of WMJ Editor, Dr. Peteris Apinis. He said that over the past year four journals had been published, 35 articles, four interviews and documents from the Council session and the General Assembly. The length of the Journal remained unchanged at 40 pages plus a cover page. The Journal was in digital format and was also sent to libraries in printed format. Demand for the paper version was increasing. He said they were now working to make the WMJ accessible to a larger audience and to raise interest in reading it. He hoped to be able to report some progress at the General Assembly in the autumn.
Public Relations
The Committee received the Public Relations Report for 2015/16.
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Secondments/Internships
The Committee received an oral report from the Secretary General. He reported that the WMA continued with its internship programmes with the IFMSA which had started in 2013, and with the University of Pennsylvania since 2014. A medical student from Indonesia was now doing an internship and further interns were expected to join during the year. Three bioethics students from Pennsylvania would conduct internships at the WMA office in the summer.
Saturday
Reconvened Council
Mohammad Wassim Maaz
The reconvened Council meeting began with delegates standing for a minute's silence in memory of Mohammad Wassim Maaz, the Syrian paediatrician, who had been killed in an air strike at the al-Quds hospital in Aleppo three days earlier.
Medical Ethics Committee
Refugees and Migrants
The 
Health Databases and Biobanks
The Council agreed that the proposed WMA Declaration on Ethical Considerations regarding Health Database and Biobanks be circulated to NMAs, that comments be invited from expert organisations outside the WMA and that a further meeting of the Work Group should take place in September to finalise a document to be presented to the Council in Taipei.
Participation of Physicians in Pre-Natal Gender Selection
The Council agreed to send back the proposed Revision of the WMA Statement on the Participation of Physicians in Pre-Natal Gender Selection to the rapporteur to analyze in relation to existing WMA policy on related topics. If the substance of the Statement is not sufficiently covered in the existing policies, the Statement will be reconsidered by the committee.
Quality Assurance in Medical Education
The Council agreed that the proposed Declaration on Quality Assurance in Medical Education should be circulated to NMAs for consideration.
Classification of 2006 Policies
The Council agreed to the Committee's recommendations on classifying policies that were 10 years old
Finance and planning committee Membership Dues Payments
The Council approved the document on Membership Dues Payments for 2015 and the interim Financial Statement for 2015.
WMA Statutory Meetings
The Council agreed the recommended venues and dates for future meetings.
Socio-medical affairs committee
Doctors for Health Equity
Ageing
The Council considered the proposed Statement on Ageing and approved the document as amended.
Zika virus
The Council considered the proposed Resolution on the Zika Virus Infection. A further debate took place about the need to include men as well as women among those who need to be advised on this issue. This was supported and the Council agreed that the document, as amended, be approved and forwarded to the General Assembly for formal adoption.
It was also agreed that a separate general document should be prepared on pandemic management.
Role of Physicians in Preventing the Trafficking with Minors and Illegal Adoptions
The Council agreed that the proposed Statement be circulated among members for comments.
Armed conflicts
The Council agreed that the proposed new Statement on Armed Conflicts should be circulated among NMAs for comments.
Occupational Health
The Council agreed that the new Resolution on Occupational and Environmental Safety as well as Gender Aspects be circulated to NMAs.
Ageing
The Council agreed that the Statement on Ageing be forwarded to the General Assembly for adoption.
Boxing
The Council agreed that the proposed Statement on Boxing be circulated the NMAs for consideration.
Tobacco
The Council agreed that the proposed revision of the WMA Resolution on the Implementation of the WHO Framework Convention on Tobacco Control be forwarded to the General Assembly for adoption.
Obesity in Children
The Council agreed that the proposed Statement on Obesity in Children should be recirculated to NMAs for reconsideration.
Physicians' Right to Information
The Council agreed that consideration of the proposed Declaration on Physicians' Right to Information about the World Medical Association and its Policies be postponed to the next meeting in Taipei in October.
Professional Autonomy of Physicians
The Council agreed to the request that the proposed Declaration on Professional Autonomy of Physicians as the Main Condition for Implementation of the Human Right to Health be withdrawn.
Fossil Fuel Divestment
The Council agreed that the proposed Statement on Divestment in Fossil Fuels be recirculated to NMAs for comments.
Global Medical Electives
The Council agreed that the proposed Statement on Ethical Considerations in Global Medical Electives be forwarded to the General Assembly for adoption.
Female Genital Mutilation
The Council agreed that the Statement on Female Genital Mutilation be approved and forwarded to the General Assembly for adoption.
Body Searches of Prisoners
The Council agreed that the Statement on Body Searches of Prisoners be approved and forwarded to the General Assembly for adoption.
Cyber Attacks on Health and other critical infrastructures
The Council agreed that the proposed Statement on Cyber-Attacks on Health and Other Critical Infrastructures be circulated to NMAs for consideration.
Medical Tourism
The Council agreed that the proposed Statement on Medical Tourism be circulated to NMAs for consideration.
Medical Cannabis
The Council agreed that the proposed new Statement on Medical Cannabis be circulated to NMAs for comment.
Classification of 2006 Policies
The Council agreed the recommendations for reclassifying policies that were 10 years old.
World Health Assembly
Clarisse Delorme reported on the work being done to prepare documents for the World Health Assembly the following month.
Dr. Kloiber said that one issue that would be raised at the WHA was that of the health work force. The United Nations Secretary General had set up a high level commission to discuss this issue and in its evidence to the panel, the WMA had stressed the importance of the health work force as an investment not a cost. The WMA looked forward to the recommendations from the Commission in order to help take this matter forward. The Chair then brought the meeting to a close.
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Recognizing that the WHO has designated the Zika virus infection a global health emergency, the WMA provides the following recommendations. 1. WHO should work with ECDC, CDC and other disease control organisations to better understand the natural history and current epidemiology of Zika virus infection. 2. Information should be disseminated widely to advise and protect all women and men who live in or must travel to Zika-affected areas and who are considering becoming parents. Advice should also include recommendations for women who are already pregnant who may have been directly exposed to the Zika virus or whose partners live
Preamble
Currently, a very large number of people are seeking refuge and/or asylum; some are fleeing war zones or other conflicts, others are fleeing from desperate poverty, violence, and other injustices and abuses with potentially very harmful effects to mental and physical health.
The global community has been ill prepared for handling the refugee crisis, including addressing the health needs of those seeking refuge.
The WMA recognizes that mass migration will continue unless people are content to stay in their birth countries because they see opportunities to live their lives in relative peace and security and to offer themselves and their families the ability to live lives with opportunities for fulfilment of various sorts, including economic improvement.
The global community has a responsibility to seek to improve the lot of all populations, including those in countries currently with the poorest economies and other key factors. Sustainable development will give all populations improved security, and economic options.
The WMA recognizes that warfare and other armed conflict, including continuous civil strife, unrest and violence, will inevitably lead to people movement. The worse the conflict the higher the percentage of people who will want to leave the conflict zone. There is a responsibility for the global community, especially its political leaders, to seek to support peace making and conflict resolution.
The WMA recognizes and condemns the phenomenon of forced migration, which is inhumane and must be stopped. Such cases should be considered for referral to the International Criminal Court.
Principles
The WMA reiterates the WMA Statement on Medical Care for Refugees originally adopted in Ottawa, Canada in 1998 which states:
• Physicians have a duty to provide appropriate medical care regardless of the civil or political status of the patient, and governments should not deny patients the right to receive such care, nor should they interfere with physicians' obligation to administer treatment on the basis of clinical need alone • Physicians cannot be compelled to participate in any punitive or judicial action involving refugees, including asylum seekers, refused asylum seekers and undocumented migrants, or Internally Displaced Persons or to administer any nonmedically justified diagnostic measure or treatment, such as sedatives to facilitate easy deportation from the country or relocation. • Physicians must be allowed adequate time and sufficient resources to assess the physical and psychological condition of refugees who are seeking asylum. • National Medical Associations and physicians should actively support and promote the right of all people to receive medical care on the basis of clinical need alone and speak out against legislation and practices that are in opposition to this fundamental right.
WMA urges governments and local authorities to ensure access to adequate healthcare as well as safe and adequate living conditions for all regardless of their legal status.
WMA Council Resolution on Refugees and Migrants
Adopted by the 203 rd WMA Council Session, Buenos Aires, April 2016
WMA Council Resolution on Zika Virus Infection
Adopted by the 203 rd WMA Council Session, Buenos Aires, Argentina, April 2016 in or have travelled to Zika-affected areas.
Relevant agencies, including WHO,
should gather data on the efficacy of different mosquito control methodologies, including the potentially harmful or teratogenic effects of the use of various insecticides. 4. Work on diagnostic tests, antivirals, and vaccines should continue with an emphasis on producing a product that is safe for use in pregnant women and public funding should be assured for this research. When such products are developed states should ensure that they are available to, and affordable by, those most at risk. 5. States which have witnessed the delivery of a number of babies with microcephaly and other fetal brain abnormalities must ensure that these infants are properly followed up by health and oth-er services, and provide support to families seeking to cope with a child with developmental abnormalities. Wherever possible research on the consequences of microcephaly should be published, to better inform future parents, and to allow the development of optimal service provision.
Mr. Nigel Duncan, Public Relations Consultant, WMA
The Sixty-ninth session of the World Health Assembly, the supreme decision-making body of the World Health Organisation, was held in Geneva from May 23-28. During the week, delegates agreed resolutions and decisions on air pollution, chemicals, the health workforce, childhood obesity, violence, non-communicable diseases, and the election of the next Director-General. As usual the meeting attracted to the Swiss city a galaxy of world leaders, health ministers, chief medical officers, global leaders from the health professions and countless lobbyists. Thousands of delegates from the WHO's Member States attended the Assembly, including many WMA leaders.
Once again an enthusiastic group from the Junior Doctors Network ( JDN) were active in presenting WMA policy on a wide range of topics.
WHPA Regulation Conference May 21-22
For the WMA, the week began with the fourth World Health Professions Alliance Regulation Conference, held at the Crowne Plaza Hotel in Geneva. The two-day conference, which attracted an audience of 260 people from 47 countries, focused on three major areas -balancing regulation of individual health professionals and of health services, health professional regulation and trade agreements, and the Sustainable Development Goals.
The first speaker, Me André Gariépy, Commissioner for the Recognition of Professional Competence at the Government of Quebec, Canada, delivered a talk entitled 'International regulation rather than national regulation'. He said that globalization and labour mobility were putting pressure on the services sectors and said that calls for simplification of regulation, aiming at internationalization of professions, were often made. He discussed the different drivers for internationalization of professions and said that the universal good was a driver for the profession.
Mrs Hélène Leblanc, Head of Public and
International Affairs at the French Chamber of Pharmacists, spoke about the European Union regulation of healthcare and the implications for health care and health professionals. She talked in particular about qualification recognition and the need to strike the right balance between the mobility of health professionals and allowing free movement while protecting patients. She said that health workers in the EU under investigation in their own country could simply move to another country and practice. This was a challenge for regulators. The key was that competent authorities must exchange information. 
World Health Assembly Week
Geneva May 23-28 2016
Nigel Duncan
BACK TO CONTENTS lenges in analyzing the agreements and their implications for health professionals and health systems, as well as engaging in advocacy, was the lack of transparency. Access to negotiating texts was limited -the texts were generally not publicly available.
Civil society had to rely on leaked texts.
Opportunities for engagement were often quite limited as well and stakeholder sessions were often poorly attended and seemed to have limited impact.
She said the TTIP agreement might have broad potential effects on public health and national health and healthcare regulation, including the supply, distribution and movement of health care workers. Its consequences needed to be weighed against the relatively modest economic benefits. She said that TTIP would put corporate interests above those of health.
Dr. Wiley said that this new generation of negotiations had occurred largely outside of existing World Trade Organisation structures. The purported goal of the negotiations was to establish a new model for all future agreements -and, de facto, a new global trade governance framework. The focus of the negotiations had generally been reductions in non-tariff barriers to trade, regulatory harmonization with the goal of further liberalization and ultimately economic growth. But a key question for the health sector was at what cost? She spoke about the Investor State Dispute Settlement (ISDS) mechanism providing a mechanism for investors to bring claims against governments and seek compensation. It provided new and novel opportunities for multinational corporations to challenge domestic laws that threatened their interests. There was concern and some evidence that the mere availability of ISDS might deter governments from adopting laws and regulations that might be targeted for challenge by investors -and this included policies to advance universal coverage including access to medicines.
With respect to health professions' education, she said there was speculation that some provisions, including potentially state-owned enterprise provisions, could be used to incite privatization of higher education.
Dr. Wiley concluded by saying that these trade agreement negotiations might help or hinder efforts to realize universal health coverage and social accountability. There were clearly risks. The health and health care consequences of these agreements must be weighed against potential economic benefits. The implications for health and health care needed to be considered in negotiations and the health sector needed to engage in these negotiations.
Dr. Carmen Catizone, Executive Director of the National Association of Boards of Pharmacy, talked about the effect of technology on health care regulation. Internet web sites and the products and services being offered by them were reshaping the traditional delivery of care. There were problems to be solved about the lack of connectivity of devices. Less than one per cent of all the world's devises were actually interconnected. There was also the widespread availability on the web of illegal and fraudulent drug sites. He spoke about the Dot Pharmacy project that was accessible to accredited organisations to fight counterfeit drugs on the web. It was established to regulate pharmacists online because 96 per cent of internet drug outlets were illegal.
Day Two of the conference looked at balancing regulation of individual health professions and of health services, and it opened with a speech from David Benton, CEO of the National Council of State Boards of Nursing. He set the context of the changes facing regulators and health systems and talked about the emerging trends that regulatory bodies needed to address. These trends could not be addressed in isolation, but needed to be considered as part of a comprehensive approach to dealing with the reality of a complex adaptive system. He spoke about improvements in joint collaboration and said that protecting the public was not uniquely the responsibility of the individual practitioner, nor was it the responsibility of the regulator, the educator or even the employer. It was a shared responsibility in which they all had to play a part. They were simply instruments in an orchestra that collectively could achieve a miracle.
Martin Fletcher, CEO of the Australian Health Practitioner Regulation Agency, spoke about regulatory principles in Australia that helped the health system regulators work together. The goal of protecting the public from harm was shared with many players, including governments, service providers, professional associations and health care consumers themselves. Working together was not an optional activity. It was a core activity. Dr. Margaret Grant, former CEO of the Australian Physiotherapy Council, talked about riskbased approaches to regulation, which she said had the potential to deliver a range of benefits. But for health, it was relatively new. She referred to moving from a light touch to a right touch approach to regulation and said that risk-based regulation of health workers must seek and address the root cause of the risk.
Katya Maznyk, CEO of the Canadian Alliance of Physiotherapy Regulators, stressed the need to focus on patients, patient outcomes and quality of care. She discussed collaborative initiatives that focused on competencies, shared roles and responsibilities and patient engagement to improve the delivery of health services. She explained how the physiotherapy profession used national accepted competencies, shared standards of practice and a code of ethics to promote quality and consistency in regulatory practices. However, she argued that a barrier in inter-professional collaboration could be differential pay structures for different professions. 
'Insecurity and Social Determinants of Health'
The following day, Monday May 23, a side event was organised by the WMA and the Junior Doctors Network, jointly with the International Committee of the Red Cross, held at the ICRC's headquarters. The purpose of the well-attended event was to identify social determinants of health as potential drivers of violence, to explore strategies to address health challenges through SDH in terms of prevention, ensuring safety of patients and health professionals, and to raise awareness of the relevance of SDH as a way forward to protect health and prevent insecurity.
The keynote speech was given by Sir Michael Marmot. He said that the different aspects of insecurity were linked -social insecurity, economic insecurity, political insecurity and insecurity in terms of safety and peace. The social determinants of health were the drivers of conflict as well as the consequences of conflict and the drivers of health inequalities. Insecurity came from the detrimental effects on the health of whole populations, on the social determinants of health and on the effects of other countries through refugees seeking asylum and insecure borders.
Sir Michael argued that the direct effects of conflict of death, physical and mental morbidity and disability had to be added to the considerable indirect effects due to the breakdown of social life and infrastructure.
These included the destruction of education and health systems, macroeconomic and household economic losses, population relocation and the destruction of social networks and detrimental environmental aspects.
He said that the main countries where the world's refugees came from were Syria, Afghanistan, Somalia, South Sudan and the Congo, all areas of great conflict. This mass migration would continue unless and until people were content to stay in their birth countries because they saw the opportunities to live their lives in relative peace and security.
He went on: 'We need urgent action to prevent the consequences on the health of a whole population, the resulting problem of refugees, insecure borders and the violation of human rights. We need action to prevent the random sexual violence that women face, the great mortality and morbidity that children suffer, the widespread loss of jobs adults face and the collapse of health service systems. The unrelenting poverty and oppression that flow from conflict are indefensible.'
Action was required across all sectors to give every child the best start in life, to enable all children, young people and adults to maximise their capabilities and have control over their lives, to create fair employment and good work for all, to create and develop healthy and sustainable places and communities and to strengthen the role and impact of ill health prevention. This, he argued, was why it was important to tackle the social determinants of health around the globe. In short, a world where social justice was taken seriously. The WHO Framework of Engagement with Non-State Actors, adopted after more than two years of intergovernmental negotiations, provides the Organization with comprehensive policies and procedures on engaging with nongovernmental organizations, private sector entities, philanthropic foundations and academic institutions.
On Sustainable Development Goals delegates agreed a comprehensive set of steps that lay the groundwork for pursuing the health-related Goals. They agreed to prioritize universal health coverage, and to work with actors outside the health sector to address the social, economic and environmental causes of health problems, including antimicrobial resistance.
On road traffic deaths and injuries delegates adopted a resolution requesting Member States to accelerate implementation of the outcome document of the Second Global High-Level Conference on Road Safety 2011-2020 held in November 2015, and on nutrition they adopted two resolutions urg-ing countries to make concrete policy and financial commitments to improve people's diets, and calling on UN bodies to implement national nutrition programmes and support monitoring and reporting mechanisms.
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The titled ethics committee and, if required by national law, the approval of a competent authority. There have been, during the years of the elaboration of the new document, several attempts to weaken specifically this latter provision, which has been, however, confirmed as it stands since 2006.
As the previous one the revised recommendation is based in the framework of the Council of Europe given by the Oviedo Convention 3 and by the Additional 4 protocol on biomedical research. The recommendation is aimed to give a synergy between the protection of the human rights of the donor of the material and the need of research based on human tissues becoming more and more important. It addresses all researchers including researching physicians. It is up to national legislators how and in which way proposals of professional or other groups -NGOs -are respected or followed during the procedure of the implementation of the recommendation into the legal system.
This overview follows the structure of the recommendation and is formulated narrow to its wording, which is sometimes quoted, to prevent any misunderstanding of the legal instrument which covers research on stored biological materials as defined by its scope.
Scope
The recommendation applies to the obtaining of biological materials of human origin for storage for future research purposes, to the storage of such materials for future research purposes and to the use in a research project of those materials that are stored or were previously obtained for another purpose, including a previous research project. It does not apply to embryonic and foetal biological materials and not to the use in a specific research project of human materials removed for the sole purpose of that project. (Covered by the Research protocol, see footnote 4). Associated personal data are included in the scope. A definition of identifiable and non identifiable biological material is given in the text.
General provisions
General provisions address different aspects of the research in view. The physical risks arising from removal of biological materials for storage for future research should be minimised. Other risks for the donor and, where appropriate, for the family or for persons in the same group as the donor, related to research activities, in particular the risks to private life, should be minimised also. Risks should not be disproportionate to the potential benefit of the research activities. Appropriate measures should be taken to prevent discrimination against, and to minimise the likelihood of stigmatisation of, any person, family or group. Refusal to give consent to or authorisation for the removal, storage or research use of biological materials or the withdrawal or alteration of the scope of the consent or authorisation should not lead to any form of discrimination against the person concerned, in particular regarding the right to medical care. Biological materials of human origin should not, as such, give rise to financial gain. Confidentiality on any information of personal na-
Elmar Doppelfeld
Council of Europe Recommendation on Biobanks
GERMANY Biobanks ture collected in removing, storing or using biological material or in obtaining by the research must be safeguarded according to the rules for the protection of private life. This provision applies also in transfer of biological materials. Member States are invited to improve the interest of the public on research on biological materials by appropriate information. Member States are free to introduce wider protection than is stipulated in the recommendation.
Obtaining and storage for future research
Introductory remarks. Obtaining human biological material for future research can in a specific manner violate human rights. Therefore this recommendation entails rather strong and detailed provisions. These provisions address different central fields. Valuable information is the appropriate basis for a free informed consent of the donor of the biological material. If this person is not able to consent according to law, e.g. because of age or disease, "free informed consent" is substituted by "authorisation". The manner and the provisions for that authorisation differ from State to State. Therefore the recommendation as a legal instrument uses a rather specific wording to cover these different regulations: "authorisation of his or her representative or an authority, person or body provided for by law". To facilitate the understanding of this article the expression "legal representative" is used addressing the various regulations. However independent from any internal regulation, the legal representative receives the same information and exercises the same rights as the represented person if being able to consent. Usually consent or authorisation are given for specific research projects. In contrast specific research projects are not yet identified in the moment of storage of material for future research. It is accepted more and more that an autonomous person or the legal representative can consent also to this situation on the basis of appropriate information (see below). The person may define restrictions of the scope of the research and may ask to be contacted before any other use of the material. To safeguard human rights the donors are insured that the material is only used for research projects reviewed by an ethics committee and, if required by law, approved by a competent body. These two basic conditions for broad consent are taken over from the former recommendation. Finally: consent or authorisation is needed for the use of different materials: those removed specifically for future research, materials already used for research and afterwards stored and materials removed for other purposes than research, e.g. for diagnosis or treatment, often known as "left overs." For person from whom this material has been removed the term "donor" is used in this text.
Information
Prior to consent to or to authorisation for the storage of biological materials for future research, the person concerned or, in case of a donor not able to consent, the legal representative should be provided with comprehensible information that is as precise as possible in view of the nature of any envisaged research use and the possible choices that he or she could exercise, the conditions applicable to the storage of the materials, including access and possible transfer policies and any relevant conditions governing the use of the materials, including re-contact and feedback .The donor or the legal representative should also be informed of the rights and safeguards provided for by law, and specifically of his or her right to refuse consent or authorisation and to withdraw consent or authorisation at any time. This information should also include any possible limitation on withdrawal of the consent or authorisation. Prior to the removal of biological materials the donor or the legal representative should be provided with additional information specific to the intervention carried out to remove the materials.
Biological materials from persons able to consent
Biological materials should only be removed for storage for future research with GERMANY the prior, free, express and documented consent of the donor given the information as outlined above. Biological materials previously removed for another purpose -sometimes addressed as "left overs in clinical routine" -should only be stored for future research with the consent of the person concerned as provided for by law. Whenever possible, consent should be requested before any removal of biological materials. Biological materials previously removed for another purpose and already non-identifiable may be stored for future research subject to authorisation provided for by law.
Council of Europe
Biological materials from persons not able to consent
Research on biological materials from persons not able to consent, e.g. minors or adults with specific diseases, may be justified. However the obtaining and the use of these materials require specific protective provisions. Biological materials from these persons who, according to law, are not able to consent "should only be obtained or stored for future research having the potential to produce, in the absence of direct benefit to the person concerned, benefit to other persons in the same age category or afflicted with the same disease or disorder or having the same condition, and if the aims of the research could not reasonably be achieved using biological materials from persons able to consent." Under this precondition, quoted from the recommendation, biological materials should only be removed from a person not able to consent if the removal only entails minimal risk and minimal burden and with the written authorisation for such removal given by the legal representative. The necessary authorisation should be specific to the intervention carried out to remove the materials and as precise as possible with regard to the envisaged research use. Biological materials previously removed for another purpose from a person not able to consent should only be stored for future research with the authorisation given in the same procedure as mentioned above. Whenever possible, authorisation should be requested before any removal of biological materials. There are specific provisions for the authorisation procedure. If the person not able to consent is an adult, he or she should, as far as possible, take part in the authorisation procedure. If the person not able to consent is a minor, his or her opinion should be taken into consideration as an increasingly determining factor in proportion to age and degree of maturity. Any objection by the person not able to consent should be respected. Any wishes previously expressed by such a person should be taken into account. Where a donor, not able to consent in the moment of removal of biological material, attains or regains the capacity to consent, reasonable efforts should be made to seek his or her consent for continued storage and research use of his or her biological materials. Biological materials previously removed for another purpose from a person not able to consent and which are already non-identifiable may be stored for future research subject to authorisation provided for by law.
Right to withdraw consent or authorisation
The donor of identifiable biological materials stored for future research should, without being subject to any form of discrimination, in particular regarding the right to medical care, retain the right to withdraw consent at any time or to alter the scope of that consent. When identifiable biological materials are stored only, the person who has withdrawn consent should have the right to have, in conformity with national law, the materials and associated data either destroyed or rendered non-identifiable. The donor considering withdrawing consent should be made aware of any limitations on withdrawal of his or her biological materials.
The legal representative having authorised the storage for future research of identifiable biological materials removed from a person who is not able to consent, should have the same rights as listed above. There should be no form of discrimination for the donor, in particular regarding the right to medical care. Where a donor attains or regains the capacity to give consent, he or she should have the rights to withdraw the authorisation under the conditions as outlined.
Removal of biological material from a deceased person
Biological materials should only be removed from the body of a deceased person for storage for future research with the consent given during life or with authorisation provided for by law. Biological materials should not be removed if the deceased person is known to have objected to it.
Governance of collections
General conditions
The storage of biological materials to be used for future research should only be done in a structured manner and in accordance with principles of governance as laid down in the recommendation. The person and/or institution responsible for the collection should be publicly known. Transparency and accountability should be the leading principles of the management. To this end information on specification, access to, use and transfer of the stored material should be publicly available. Before any change of the purpose of a collection an independent examination of its compliance with the provisions of the recommendation should be carried out. As consequence of this examination may result the requirement of renewed consent or a renewed authorisation in relation to the change of the purpose. Each sample in the collection should be appropriately documented and traceable. For an appropriate documentation information on the scope of any consent or authorisation is necessary. Quality assurance measures should be in place concerning an appropriate security and confidentiality during establishment of the collection, storage, use and for the case of transfer of biological materials. Transfer of the whole or of part of the collection as well a its closure may only be performed following established procedures in accordance with the original consent or authorisation. The exercise of the right to withdraw consent or authorisation needs updated information on management and use of a collection. This information should be available therefore for the persons concerned, the donor or the legal representative. For more public acceptance of a collection are advisable regular reports on past or envisaged activities, information on access granted to materials and on progress in research projects using the stored samples. The publication of a summary of findings on completion of each research projects will contribute to the public acceptance of collections.
Individual feedback
Article 10 of the Oviedo Convention underlines for the health field the right of a person "to know or not to know", which is taken up by the recommendation. In line with this provision clear policies are required to inform on findings relevant for the health of the persons detected in the use of their biological materials. The same information should be given when persons, who are not able to consent, are the source of the material. This feedback should take place within a framework of appropriate health care or counselling. The wishes not to be in formed on these findings should be observed.
Access
For safeguarding an appropriate access to and use of stored biological materials by researchers clear conditions should be set up and documented. These conditions should include the respect for any restrictions defined by the donor or during the procedure of authorisation. Transparent policies of access and oversight of a collection should be published. Appropriate access mechanisms may contribute to maximise the value of collections. Traceability of the use of the stored materials can have an additional benefit.
Transborder flows
Research on human biological materials as all research is carried out in an international context, exchange of samples between researchers working in different States with often different levels of protection is common. In relation to this fact the recommendation requires that in case of any transfer of materials to another State an appropriate level of protection is ensured. This can be achieved by the law of the accepting State. As a solution are also considered legally binding and enforceable instruments adopted and implemented by the parties involved in the transfer for future research activities. To this end may serve a documented and signed agreement between the sender of the materials and the recipient. The agreement should include statements on consent or authorisation and on relevant restrictions as defined by the donor or by the legal representative.
Oversight
A collection may be established only after an independent examination of its compliance with the provisions of the recommendation. Once established a collection should be subject to an oversight proportionate to the risks for the donors of the materials stored in that collection. The specific aim of this oversight is safeguarding the rights and interests of the donors in view of the research activities of the collection. The recommendation entails oversight mechanisms, understood as minimum items. Object of such an oversight is the implementation of security measures and of procedures on access to, and use of, biological materials. The above mentioned system of annually reports is another object. The oversight includes any changes in the risks to the donors of the collected material. As a result the revision of policies may be requested. The provision of appropriate information to the donor or to the legal representative responsible for a given authorisation on changes in the management of the collection is part of the oversight. This is a condition for exercising the right to withdraw. Another important issue for the oversight are development and implementation of feedback policies including a regular review. Oversight mechanisms may be adapted to evolutions of the collection and of its management.
Use of biological materials in a research project
General provisions
This chapter of the recommendation can be considered as meeting point of requirements of research and of protective provisions. As a basic principle is accepted that biological materials can only be used if the envisaged research project is within the scope of a given consent or authorisation. If this condition is not fulfilled consent or authorisation to use the material for that specific research project should be sought. To this end reasonable efforts are required to contact the donor or the person or institution entitled to give an authorisation. It may happen that a person, in the moment of removal of biological material or later on , expresses the wish to be no more contacted. This wish should be ob-served. In case of unsuccessful attempts of these contacts the biological materials may be used if an independent evaluation states the fulfilment of the following conditions as a whole. Evidence is provided that reasonable efforts have been made to establish the above mentioned contactsa sole declaration of the researcher is not considered as sufficient. The research project addresses an important scientific interest and is in accordance with the principle of proportionality. The aim of the research can only be achieved using these materials which can not be substituted by materials for which consent or authorisation can be obtained. Finally it is not known that the donor or the legal representative has expressly opposed such research use. These are of course rather strong conditions for scientific use of materials without consent or authorisation. The recommendation tries to open the way in a distinct frame to bind a decision on specific conditions to enable a synergy of the needs of research and of the protection of individuals. Identifiability and non-identifiability play a major role in research. The use of material in an identifiable form should be justified in advance in the research protocol to be submitted for examination. Rendering materials non-identifiable may be considered as an easier way for their use. However the recommendation requires that rendering materials non-identifiable is depending on the consent of the donor or of the legal representative . Both of them may define restrictions which must not be violated using these materials when rendered nonidentifiable. The recommendation addresses specifically the attention to any authorisation by law. The research use of biological materials removed of persons not able to consent is object of a controversial discussion. The recommendation entails the following provision, elaborated in line with the Oviedo Convention and the Additional protocol concerning biomedical research: "Biological materials from persons who, according to law, are not able to consent should only be used for research hav-ing the potential to produce, in the absence of direct benefit to the person concerned, benefit to other persons in the same age category or afflicted with the same disease or disorder or having the same condition, and if the aims of the research could not reasonably be achieved using biological materials from persons able to consent."
Independent review
The recommendation requires an independent review of research proposals using biological materials. This review follows the system established in the research field. By an independent examination scientific merit, importance of the aim and the ethical acceptability of the research have to be proved. No research should be undertaken without this examination. This examination is usually carried out by an ethics committee according to national law. The recommendation states explicitly that national law may in addition require approval by a competent body. Principles concerning ethics committees are contained in Chapter III of the Additional Protocol concerning biomedical Research (see footnote 4). The recommendation proposes Member States to apply these principles to the review of the research project within its scope. Review procedures should be flexible and may therefore be adapted to the nature of the research and to the possible identification of the donors.
Availability of results
The recommendation tries to prevent the well known "silent death or silent disappearance" from research projects. Therefore on completion of a project a report or summary should be sent to the ethics committee or the competent body and to the collection granting the materials. Another well problem is the scientific publication of results. It seems that researchers legally cannot be forced to publish results of their research.
The same difficulty was met during the elaboration of the Protocol concerning biomedical research (see footnote 4). The recommendation uses a nearly identical wording: "The researcher should take appropriate measures to make public the results of research in reasonable time."
Closing remarks
Research on human biological materials addresses two fields of problems: the removal of the donor and the scientific use. Whereas it is unanimously accepted that the removal needs consent or authorisation the conditions for use are still in discussion. It is argued, that there is no physical harm to a person if his or her materials, separated from the body, are used. However the idea is since decades adopted also that the donor should have the right to define this use -treatment and/or research. The way for the protection of this right is object of controversial discussions. The recommendation agreed by 47 European governments shows a solution respecting as far as possible the different positions and national legislations.
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Introduction
Zika virus, first isolated in 1947 in rhesus monkeys, is an arbovirus, member of the Flaviviridae family. First found in humans in Nigeria in 1954, for 50 years was described as a cause of sporadic human infections in Africa and Asia, until in 2007 an epidemic took place in Micronesia [2,3] (C). More recently in Brazil, The Ministry of Health, as verified by the data provided by the Live Births Information System -SINASC, has recorded substantial increase in the number of cases of microcephaly after a high incidence of infection. The clinical features and natural history of Zika infection are based on a limited number of case reports; however, it is clear that vertical transmission of the virus can occur during pregnancy, as seen in a series of reports of cases of microcephaly among children whose mothers were infected with Zika virus [4, 5] (C) [6] (D). In view of these aspects, the development of clinical guidelines regarding the knowledge acquired to date on an association between infection with Zika virus and its effects on pregnancy and childbirth is imperative in order to delimit and advise on panoramas related to preconception counseling, prenatal, labor, postpartum and newborn care. 
Objectives
Material and Methods
The evidence used to evaluate the occurrence of infection with Zika virus during pregnancy was obtained according to the following steps: preparation of the clinical question, structuring of the question, search for evidence, critical evaluation and selection of evidence. 
Structured questions
Inclusion criteria for studies retrieved
Selection of studies, assessment of titles and abstracts was conducted by two researchers (R.S.S. and W.M.B.) both independent and blinded. Whenever the title and the summary were not enlightening, researchers sought the full article. Case reports, case series and guidelines were included in the evaluation. Narrative reviews were included in the reading with the purpose of retrieving reference that could have been lost in the initial search strategy. Physiological reports or studies based on animal models, as well as those unrelated with our P.I.C.O. components, were not included. Only articles whose full text was available were included in the guideline. We included studies available in Portuguese, English, French or Spanish.
Studies retrieved
After entering the search strategy in the primary databases the assessment of titles and abstracts led to the selection of 288 studies.
Evidence selected
The studies considered for full text reading were assessed according with the set inclusion and exclusion criteria, P.I.C.O., language and availability of the full text (Figure 1 ).
During pregnancy, what is the association between Zika virus and microcephaly?
In Figure 1 . Flowchart for study selection effect. The first point refers to the prevalence of the historical birth of infants with malformations of the central nervous system in Brazil, which is about five cases per 100,000 live births, less than the estimates recently made of 10 to 20 cases per 100,000 live births. This may indicate the occurrence of underreporting of microcephaly in the country [18] (D). Thus, any active search for this congenital malformation would be able to increase its prevalence, with a clear excess in the number of cases. Another point related to the increase in the number of cases would be the change in diagnostic criteria, accepting as microcephaly cases of head circumference measuring less than 33 cm, and possibly explaining a situation of overdiagnosis. Since the infection with Zika virus in newborns and pregnant women was not confirmed by laboratory tests at first, another relevant question is that the history of nonspecific rash referred to during pregnancy is subject to recall bias and may have incurred potential misclassification regarding exposure to Zika virus. Regardless of any controversies to confirm, or not, the role of Zika virus in the genesis of cases of microcephaly, measures to prevent infection with this virus are necessary and unquestionable.
What is the Association Between Zika Virus and Guillain-Barré Syndrome? Is it Different During Pregnancy? Can it Affect the Fetus?
Guillain-Barré syndrome (GBS) is a neurological disease that consists of an acute autoimmune inflammatory demyelinating polyneuropathy. This is the leading cause of widespread flaccid paralysis in the world with an annual incidence of 1 to 4 cases per 100,000 inhabitants [19] (D). It typically appears in two to three weeks after nonspecific viral infection. The occurrence of neurological syndromes after infectious processes by dengue virus and chikungunya has been described since the late 1960s, and with Zika virus infection since 2007, especially after the outbreaks in Micronesia and in French Polynesia [2] (C).
In the primary databases consulted, there is only one case report on French Polynesia in which GBS was diagnosed in a patient infected with Zika virus. The report showed the first case of GBS manifested seven days after febrile illness characterized as Zika virus infection based on serological results [20] (C). The association between Zika virus infection and Guillain-Barré syndrome still needs confirmation through analytical studies. One factor that hinders greater understanding about this association in Brazil is the lack of epidemiological data specific to this syndrome.
What are the symptoms in pregnant women with suspected Zika virus INFECTION? Are they different than in the general population?
It is estimated that 80% of people infected with Zika virus do not develop clinical manifestations as seen from epidemiological studies, however, when they appear, signs and symptoms usually are fever, pruritic maculopapular rashes, non-purulent conjunctivitis, fatigue and myalgia, and joint pain in the extremities (wrist/ankle), often associated with edema. Other unspecific manifestations that may be reported are headache, retro-orbital and abdominal pain, diarrhea, vomiting, constipation and cough [3, 4, [21] [22] [23] [24] (C). No sign is pathognomonic of infection with Zika virus. Studies specifically evaluating the population of pregnant women infected with Zika virus are rare in the literature. However, a case series conducted in Brazil revealed that 72.4% (n = 21) of the women experienced rash; 44.8% (n = 13) had fever; 37.9% (n = 11) had arthralgia; with headache in 17.2%, and pruritus in 13.8%. All pregnant women denied ophthalmologic manifestations [23] (C). In this study, other causes for the symptoms were excluded such as infection with cytomegalovirus, rubella, herpes virus, syphilis, toxoplasmosis and HIV. Nevertheless, the major problem in this assessment would be the sample which was made for the convenience of women who showed signs and symptoms suggestive of infection with Zika virus. Another point of great limitation for the interpretation of these results is the lack of statistical analysis which would make it impossible to claim that the percentages or findings are exclusive to this population or if they can be extrapolated to all presumed infections with Zika virus [23] (C).
How to make a definitive diagnosis of Zika virus INFECTION during pregnancy?
Information about laboratory abnormalities during Zika virus infection are scarce in the literature, but leukopenia, thrombocytopenia, elevation of serum lactate dehydrogenase, and elevated markers of inflammatory activity such as C-reactive protein are reported [25, 26] (C). A limiting factor that hinders a direct biological diagnosis, especially using molecular biology techniques, and may be related to false-negative results is that the Zika virus genome is made of ribonucleic acid (RNA) which is very fragile. The Zika virus can be isolated in cell cultures such as Vero cells, and its identification is done by indirect immunofluorescence. However, this technique is reserved for specialized laboratories [24] (C). Immunoenzymatic test (ELISA) for detection of immunoglobulins (IgG and IgM) and plaque-reduction neutralization test (PRNT) can be used. But there is a problem related to serological testing which is the possibility of cross-reactivity as a result of previous infection by other flavivirus [4] (C) [27] (D). The identification of viral genome by reverse transcriptase followed by real-time polymerase chain reaction (RT-PCR) from RNA directly extracted from the patient's serum and preferably collected up to the sixth day of the disease is the most sensitive and specific method for diagnosis of Zika virus infection [4, 29] (C) [28] (D). One must be aware of the possibility of false-negative results since, contrary to what is observed for other viruses, the restricted circulation of Zika virus has limited the knowledge about its actual genetic diversity.
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What is the treatment for Zika virus INFECTION during pregnancy?
There are no vaccines, preventive drugs, or specific antiviral treatments for Zika virus infection. Treatment is generally supportive and may include rest, hydration, nonsteroidal anti-inflammatory drugs or nonsalicylic analgesics used on an individual basis after careful clinical evaluation. Given that clinical diagnosis is not conclusive, and even serological analysis may fail, the use of salicylates as analgesics should be discouraged because of the increased risk of hemorrhagic events described in hemorrhagic syndromes, as in other flavivirus infections. The pathophysiology of cutaneous manifestations remains unknown, but antihistamines may be of benefit to patients, acting as a sedative and not as an agent to treat the cause of the itching [30] (D).
How is THE follow-up of pregnant women INFECTED WITH Zika virus done?
Pregnant women tested positive for Zika virus infection (identified by RT-PCR or detection of IgM/IgG immunoglobulins) should be referred for high-risk prenatal care. There are no studies with an appropriate design plan for the monitoring of pregnant women diagnosed with Zika virus aiming to assess the prognosis or quality of life. However, if the fetal ultrasound examination is normal in women tested positive for Zika virus infection, both physician and patient should considerer scheduling ultrasounds serially every 3 to 4 weeks to monitor fetal anatomy and growth [31] (D).
What are the precautions to be taken with babies born from pregnant women with a history of Zika virus INFECTION?
Targeted diagnostic tests to identify Zika virus infection should be recommended for infants with microcephaly or intracranial calcifications born to women who traveled to or lived during pregnancy in areas where the virus circulates; or children born to mothers with positive or inconclusive results for Zika virus infection. A newborn is considered congenitally infected if viral RNA or antigen is identified in any samples presented for analysis, including testing of amniotic fluid or placental cord blood analysis. For newborns with laboratory evidence of possible congenital infection with Zika virus, further clinical evaluation and monitoring are recommended. In these cases, clinical history, physical examination including measurement of head circumference, length, weight and assessment of gestational age, are needed. Neurological abnormalities, skin rashes, dysmorphic features, splenomegaly and hepatomegaly should be evaluated. Ophthalmologic evaluation and otoacoustic emission examination should be conducted before hospital discharge or within a month after birth [32] (C). For children with microcephaly or intracranial calcifications, additional evaluation should include consultation with a pediatric neurologist. Test for other congenital infections such as syphilis, toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infections should be requested. Genetic causes should also be investigated, as well as maternal substance abuse, exposure to ionizing radiation, use of teratogenic agents and infections in general [33] (D).
What care is required for newborns diagnosed with microcephaly during pregnancy?
Because of the wide variety of differential diagnosis ranging from other congenital infections, genetic abnormalities, familial microcephaly, and more, it is imperative to confirm the diagnosis of Zika virus infection in microcephalic newborns. Thus, careful history should answer the following questions: maternal history (intrauterine infections, placental insufficiency, pre-existing maternal diseases); maternal exposure to ionizing radiation or potentially teratogenic agents (drugs, alcohol, smoking, etc.); drugs used during pregnancy; presence of skin rash and other signs and symptoms of infection during pregnancy; and family history. Complete physical examination of the newborn should be performed, with the measurement of head circumference, length, weight and gestational age assessment, also including a detailed neurological examination. Ophthalmologic evaluation within 1 month after birth is recommended, including retinal assessment, since abnormal ophthalmologic findings such as macular abnormalities and optic nerve disorders are reported in microcephalic children with possible congenital infection with Zika virus [23, 24] (C). The mother must also be tested for Zika virus infection, in case this was not done during pregnancy.
REPUBLIC OF TURKEY NMA News
The Turkish Medical Association and its local body the Istanbul Chamber of Medicine in collaboration with the World Medical Association hosted a very important event on 26-27 February 2016 in Istanbul on the recent global migration crisis. The "War, Migration and Health: What Should Physicians Do?" symposium agenda included many aspects of the crisis, offering solutions as well. See Flyer of the Symposium.
The Symposium started with key speeches framing the burden as a global issue. Prof. Sir Michael Marmot, President of the World Medical Association, opened the Symposium with his marvelous key speech highlighting the inequalities in the world. From beginning to end, excellent speeches from distinguished guests were presented. Humanity, health, ethics, economic and other aspects were discussed during the Symposium. e. Physicians should advocate for peace at the global level as they are the voice of humanity.
In conclusion, the Symposium gave the organizers and participants a chance to discuss the "war" and "migration" issues in a very broad perspective. In this sense, solutions were discussed realistically and sincerely. The Symposium was full of hope that the recommendations will be implemented in real life.
The Symposium ended with accepting a communiqué including all the discussed problems and solutions [3] . The Symposium website (warmigrationhealth.com) is still active including all the details and video records of the speeches in English and Turkish.
The Turkish Medical Association and its local body the Istanbul Chamber of Medicine were honored to collaborate with the World Medical Association in organizing such a symposium on a very hot topic for the Global Health Agenda.
Hopefully, outputs of the Symposium would contribute to solving the problem(s) in the very near future. Many countries face significant problems maintaining effective health and social care systems and are unable to respond to the basic needs of refugees and migrants. War and internal conflicts in countries of origin, extreme poverty in transit countries, and limited resources and political pressure in rich destination countries are just some of the obstacles inhibiting action. The resultant impact is that refugees and migrants face severe difficulties in securing food, shelter and access to healthcare.
Doctors as the voices of solidarity and peace will work continuously in this regard…
PARTICIPATION
the WMA wishes to address these problems in an international symposium, and therefore urgently requests your participation in order to learn from your experience including. the health problems of refugees and migrants, access to healthcare, government reactions and responsive policies, experiences of healthcare workers, NMAs and NGOs, observations and recommendations.
Please see the website for details. Its purpose is to promote the partnership of the medical profession in the membercountries, to discuss common problems and to find solutions; to enable exchange of experience, strengthen the relations and elaborate common approaches in all fields of activity of the medical organizations;
to develop continuous medical education through medical congresses and other forms of mutual activity; to assist its members for improvement of their medical and management-related qualification; to establish contacts and partnership with other international organizations.
Main Goals
1. To unite and assist its members for achievement of their common aims; 2. To enable exchange of experience and develop common approaches in all fields of activity of the medical organizations; 3. To promote in the Southeast European countries the best possible medical education, medical practice and healthcare; 4. To strengthen the relations between the medical organizations of the Southeast European countries; 5. To strengthen the relations between the physicians from the Southeast European countries and the exchange of experience with their colleagues from the EU member-countries; 6. To assists its members for improvement of their medical and managerial qualification; 7. To establish contacts with similar organizations; 8. To defend the rights and interests of physicians, healthcare establishments, and medical professionals before the legislative, executive and legal authorities by submission of drafts and stands on regulations, legal proceedings, etc.
As of 2010 SEEMF intensified its activities and is holding at least two Board Meetings and a Congress each year. Self-evident of the reputation that the SEEMF has, as well as of the need of medical professionals to share their thoughts and experience was the fact that the medical associations of Azerbaijan and Moldova were accepted as members of the organization.
The multidisciplinary scientific agenda of the Congress was focused mainly on the fields of cardiology, diabetes treatment, organ transplantations and oncology. Many interesting topics were debated at a round table discussion on the issues of healthcare funding and the role of professional organizations. The high value of reports, lecturers and topics was the fact that participants were granted European certificates with the score of 15 credits. 
The Fifth international medical congress of
History in brief:
Bulgarian Medical Association was established in 1901 which made it the second professional medical association in the world after the British one. At first, its objectives were to protect the interests of the medical profession, determine their fees, but later on it began to organize the medical care across the country and determine the health policy of the state. During the communist regime the Bulgarian Medical Association was put under a ban. It has been restored after the democratic changes in 1990.
Membership: Adopted in 1999, the Act on the Professional Organizations of Physicians and Dentists legitimized the Bulgarian Medical Association and the Bulgarian Dental Association as autonomous statutory organizations. This law regulates the structure, organization and activities of the professional organisations of physicians and dentists, the conditions for practising the medical and dental professions and the liability for breaching of professional ethics. The law stipulates that all practising physicians and dentists shall be members of the Bulgarian Medical Association, respectively the Bulgarian Dental Association.
Structure and major commitments:
Bulgarian MA consists of 28 Regional Colleges. All the physicians with their full name, specialty, work address, unique identity number and qualification degrees are listed in the register of the respective Regional Medical College. Every physician holds an electronic professional card. The Association is committed to implementation of the following major commitments (as stipulated in the Act on the Professional Organizations of Physicians and Dentists): 1. to represent its members and protect their professional rights and interests; 2. to represent its members as a party to the National Framework Agreement under compulsory health insurance law; 3. to work out a Code of Professional Ethics of physicians and to supervise the compliance therewith; 4. to adopt Rules of Good Medical Practice, to propose them for approval to the Minister of Healthcare and to supervise the compliance therewith; 5. to impose the penalties provided in the Act on the professional organizations where necessary;
6. to establish and keep a national electronic register and regional registers of its members; 7. to participate in the organization and delivery of continuing professional development for physicians through the Accredita- Mission: The missions of the Association shall be to unite and organize professionals of medical science and technology, to abide by the national Constitution, laws and regulations, and to implement national policies for science and technology and healthcare. The Association shall uphold medical ethics and advocate social integrity. It shall operate with democratic principles, support freedom of scholarship, and seek to raise the technical skills of the professionals of medical science and technology. It shall promote the prosperity and development of medical science and technology, and the popularization of medical science and technology knowledge. It shall promote the growth of work forces in medical science and technology and the integration of medical science and technology with China's economic development. The Association shall provide services for its members and for professionals of medical science and
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Xiao-wei Ma NMA news technology, for the health of the Chinese people, and for socialist modernization in China.
Services provided: 1. To carry out medical exchange programs, to organize activities for research priorities and investigations, and to promote relations and collaborations among scientific disciplines and learned groups. 2. To edit and publish journals, books and materials and produce electronic audiovisual products of medical sciences, techniques, information, and popularization of medical science knowledge. 3. To provide continuing medical education and to organize its members and professionals of medical science and technology to upgrade their knowledge and raise their professional levels in medical science and technology. 4. To organize medical and health knowledge popularization and health promotion activities through various channels and in different forms to improve public health knowledge and increase the ability of the public to care for their own health. 5. To be involved in the training and examination of medical specialists. 6. To organize technical assessments of medical malpractices. 7. To organize assessment and appraisal of projects of medical science and technology, evaluations of new clinical technologies, and reviews and evaluations of decisions concerning medical science and technology, and to put forward medical, pharmaceutical and technological suggestions for evidence-based decision-making for the government. 8. To develop relations with foreign groups and professionals of medical science and technology and carry out international and Taiwan, Hong Kong, and Macao regional exchange and cooperative programs. 9. To provide consulting services on medical, pharmaceutical and health science and technology and organize exhibitions to facilitate transfer and application of medical research results. 10. To select and award outstanding achievements in medical science and technology including scientific papers and popular science writings, etc. and organize the assessment and award of the China Medical Award. 11. To find, recommend and train outstanding talents of medical science and technology; 12. To promote and award medical professionals for their medical ethics and skills, and to commend and award Association members who make outstanding contributions to the activities of medical science and technology and Association staff members who make remarkable achievements for the Association. 13. To serve its members by keeping the Party and the government informed of the views and aspirations of the professionals of medical science and technology and by protecting their legal rights and interests. And to organize programs and activities for its members. 14 
Services provided:
Member services include a patient injury and liability insurance, legal advice, membership in unemployment fund, CPD/CMEtraining, network of trusted physicians, Finnish Medical Network (Fimnet) Internet portal, and grants for training, research and for international co-operation. Members are also offered certain products, discounts and social activities. In addition they receive Finnish Medical Journal that is published in paper form weekly, and can read the electronic version as well.
Activities:
• We involve our members at regional and local level to participate policy-making of the association. • We negotiate the salaries of the physicians working in the public sector. • We foster medical ethics in several ways: Medical Ethics Committee that involves representatives also from other physician´s 
Vision:
Finnish Medical Association is a professional organization and a trade union of a unified medical profession. It benefits its members as well as key stakeholders.
International cooperation:
FMA is a member of several international physician´s organizations i. • MMA also has a separate wing for the student members.
Objectives:
• To promote and maintain the honour and interest of the profession of medicine in all its branches and in every one of its segments and help to sustain the professional standards of medical ethics. • To serve as the vehicle of the integrated voice of the whole profession and all or each of its segments both in relation to its own special problems and in relation to educating and directing public opinion on the problems of public health as affecting the community at large. • To participate in the conduct of medical education, as may be appropriate. • To promote social, cultural and charitable activities in building a united Malaysian nation. • To carry on any business, trade, joint venture, commercial arrangement, transaction or any enterprise whatsoever which may in the option of the Association be advantageous to the Association or calculated directly or indirectly to enhance any of the Association's assets, properties or rights. 
Sections, Societies and Committees Of Mma
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RMA is committed to being at the fore front of healthcare management by enhancing and integrating professionalism among its members; integrating members into policy negotiation, formulation and implementation and building alliances with other health professional association and regulatory bodies to meet the health needs and expectations of Rwandans. Guiding principles:
• Our members are our number one priority in all the work we do. We seek to build and maintain an association that is inclusive, collaborative, and accountable to physicians. We have an uncompromising commitment to serve them well, protect their interests, and contribute to their overall health and well-being. • We are committed to be in the forefront of building a stronger, higher quality health-care system for our patients, and ensuring valued and effective roles for physicians in that system.
Core values: "Integrity, Professionalism, Collegiality and Empathy."
Collaborations:
1.National collaborations Within Rwanda, the association seeks to harmonize efforts with similar organization in order to efficiently advocate for its members. The collaboration covers technical support from specialized organization and financial and policy support with public system. We 
Core and Routine activities
With its members: RMA organizes Continuous Professional Development (CPD) workshops for its members across the country, in different regions every quarter. The aim is to ensure RMA members have up to date medical information on relevant topics and targeted knowledge gaps in order to improve the quality of service provided by our members. Particular attention has been made to medical ethics which has been included in all our CPD activities. These activities are supported by the contribution paid by our members and local partner organizations. RMA organizes an annual scientific conference each year which aims to bring together scientific innovation; political leaders and implementers to discuss key topics according to the context of medical practice in Rwanda. This has been an opportunity to keep the debate alive especially on issues that affect on one hand our members' daily work and efficiency, on the other hand the healthcare system as a whole. RMA has started advocating for the professional indemnity insurance, professional consulting fees etc. for its members.
With Partners: RMA actively participates in debates and workshops organized in the country in order to keep the voice of our members represented in all circles that are impacting our work and welfare. We represent our members to the Ministry of Health; regional discussion affecting the practice of medicine; legal and trade policy discussion. We also reach out to seek for financial and technical collaboration in order to increase the capacity of the association to serve its members. Presidium of SkMA is a statutory body and has 15 members. SkMA and its professional societies and guilds can be the members of the other national and international non-governmental organisations (associations, guilds) having a similar scope of interest (EFMA, WMA, WHO, UEMS, CIOMS, CPME).
Mission and objectives of SkMA
SkMA shall:
• initiate and mediate transfer of the latest scientific professional medical, diagnostic and therapeutic information into practice in the form of continuous -further systematic education, • assert a decisive role of the professional societies mainly as expert guarantors in continuous -further systematic medical education of physicians, pharmacists and other medical workers, • initiate, submit, enforce and publish the opinions on a) the issues connected with expertise and scientifically based knowledge of medical sciences within individual medical branches; b) the issues connected with possibilities to apply top, diagnostic and therapeutic methods in medical practice; c) the issues of ethic of physicians and medical workers; d) the issues of existing and being prepared legislative standards in health care; e) the issues of specialised scopes of a further education system; f ) nomination of the experts as members of various committees, -represent its professional societies and guilds outwards with the aim to protect their justified requests and interests in relation to other subjects. NMA news tative of Zambian doctors in the diaspora with a chairman based in Geneva, Switzerland. ZMA also has regional representatives in China coordinating the Asia region, in the USA for the Americas and in New Zealand for Oceania.
Scope of
Activities of ZMA Continuous Medical Education
One of the key objectives of ZMA is to further the development of the medical profession as an instrument of social development and as an essential element for growth of society. In this regard we seek to maintain a high standard of medical practice by providing continuous medical education activities (CMEs) to our members.
With an executive committee member in-charge of CME's in place, ZMA holds CMEs across the country throughout the year.
Reports/Presentations to Parliament
ZMA is an important stakeholder in the country in the area of health. The Zambian parliament has recognized this and has in the last year invited ZMA to make presentations to the select committee on health on key health issues affecting the country. In this regard presentations on the HIV national response, maternal mortality and on social health insurance and the healthcare system in general were made during the last year.
Representation on Various Boards and Committees
Still in keeping with the ZMA's mandate of remaining relevant to the public and aiming to influence national policy in the arena of health, ZMA is represented on various boards and committees in the country. In particular, we have an executive committee member who sits on the board for the health professions council and another on the Zambia Medicines Regulatory Authority board. We also have representation on committees at the National AIDS Council and at the Ministry of Health. These are important links to ZMA because it is through these links that we get to influence national policies.
ZMA Work with the First Lady of Zambia
ZMA has recognized the unique role that the First Lady of the Republic Mrs. Esther Lungu, plays in the area of health through her charity work. She has had a lot of impact on various health issues especially relating to women and children. In recognition of this work and the impact her work has on those that are disadvantaged, she was a joint recipient of the prestigious 2015 ZMA President's award. Since the award, ZMA has worked closely with her office to support her work. In line with this, an executive committee member has since been appointed as ZMA liaison to the First Lady's office.
Workshops with Religious, Traditional and Civic Leaders
In our quest to impact the nation, ZMA has engaged national leaders at various levels on several issues of interest to the association in public interest. One area has been the issue of maternal mortality and the significant contribution made by unsafe abortions. In this regard, a series of separate workshops were organized in the last year with religious leaders, traditional leaders and members of parliament to raise awareness about this problem and to highlight how workshop participants could use their positions to make a change in their communities.
Public Health Media Work
As a way of engaging the public and ensuring our goals receive media coverage, ZMA supports public health programs on national radio and television. These are weekly programs meant to highlight key public health issues. These programs serve as a conduit through which ZMA can reach the public. In line with this, we have a weekly column in one of the national dailies dubbed the "Public Health corner." Articles from this weekly column are also placed on our website.
Upcoming Events
The 2016 ZMA Annual Scientific Conference and AGM will be held from 28th to the 30th of July 2016 at Chrismar Hotel in Livingstone. The theme for this year's meeting is "Public Health Solutions for Sustainable Development Goals." Monitoring of the Zambia Presidential and General Elections and Referendum by ZMA: On 11th August, 2016, Zambia goes to the polls in a Presidential and General election and Referendum. ZMA will be involved as elections monitors. This is in keeping with the ZMA goal to ensure we remain relevant to our time and influence national policy. ZMA is nonpartisan and we are engaged in these elections in an advisory capacity to the various stakeholders to ensure elections are held in a free and fair manner. We are especially alive to the various public health concerns that may arise during an election and that may negatively affect the voting. It is to these that we want to especially address and ensure the relevant authorities address these issues amicably.
The 2016 ZMA Annual Ball and Awards Gala will be held on 10th December, 2016 in Lusaka. The venue is yet to be confirmed. Last year's event was held at Hotel intercontinental and the Republican President, His Excellency Edgar Lungu was the guest of honor. The 2017 World Medical Association Council meeting will be held in Livingstone, Zambia in April of 2017. The meeting will be hosted by ZMA at a pleasure resort on the banks of the Zambezi River just next to the Mighty Victoria falls. This is an area in a Game Park. Guests to this meeting can plan for a holiday and experience a true safari in one of the most beautiful places in the world. Special packages in this regard will be advertised in due course. 
Moving forward from One Health Concept to One Health Approach
Following the successful Global Conference on One Health (GCOH) that was held in Madrid in May 2015, the WVA and WMA in close collaboration with the Japan Medical Association (JMA) and the Japan Veterinary Medical Association (JVMA) are preparing the 2 nd GCOH to be held on 10t-11 th November in Kitakyushu City, Fukuoka Prefecture, Japan.
The 2 nd GCOH aims to bring together Veterinarians, Physicians, Students, Public Health Officers, Animal Health Officers, NGOs and other interested parties from the different world regions to learn, discuss and to address critical aspects of the 'One Health' Concept.
The main objectives of the conference are to strengthen the links and communications and to achieve closer collaboration between Physicians, Veterinarians and all appropriate stakeholders to improve the different aspects of health and welfare of humans, animals and the environment.
The main conference sessions will focus on the issues of:
• Zoonotic diseases • Foodborne diseases • Antimicrobial resistance • Environmental hazards exposure to humans and animals More details regarding the conference and registrations will be published soon on WVA and WMA websites www.worldvet.org www.wma.net
